BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
5157 results:

  • 1. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
    Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
    JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis].
    Ding L; Wang RY; Zhang F; Wu MS; Chen B; Sun KW
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1073-1081. PubMed ID: 38621914
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Machine Learning Prediction of Lymph Node Metastasis in Breast Cancer: Performance of a Multi-institutional MRI-based 4D Convolutional Neural Network.
    Polat DS; Nguyen S; Karbasi P; Hulsey K; Cobanoglu MC; Wang L; Montillo A; Dogan BE
    Radiol Imaging Cancer; 2024 May; 6(3):e230107. PubMed ID: 38607282
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Left atrial reservoir longitudinal strain and its incremental value to the left ventricular global longitudinal strain in predicting anthracycline-induced cardiotoxicity.
    Li Z; Zhao R; Zhang Q; Shen Y; Shu X; Cheng L
    Echocardiography; 2024 Apr; 41(4):e15805. PubMed ID: 38558436
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.
    Park C; Lee HS; Kang KW; Lee WS; Do YR; Kwak JY; Shin HJ; Kim SY; Yi JH; Lim SN; Lee JO; Yang DH; Jang H; Choi B; Lim J; Sun CH; Byun JM; Yoon SS; Koh Y
    Nat Commun; 2024 Mar; 15(1):2776. PubMed ID: 38555311
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysis.
    Jung HA; Park B; Park S; Sun JM; Lee SH; Seok Ahn J; Ahn MJ
    Lung Cancer; 2024 Apr; 190():107536. PubMed ID: 38493759
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Neutrophilic Dermatosis of the Hands: A Case Report.
    Yaghoobi R; Bagherani N; R Smoller B; Pazyar N
    Acta Dermatovenerol Croat; 2023 Dec; 31(3):148-50. PubMed ID: 38439725
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
    Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
    JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Case 322: Pyothorax-associated lymphoma.
    Hu JY; Lee KH; Yun G
    Radiology; 2024 Feb; 310(2):e223090. PubMed ID: 38411510
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial.
    Xing S; Pu Y; Zhao X; Hu Y; Zhang F; Gu Z; Xu W; Fan L; Miao Y; Li J
    Braz J Med Biol Res; 2024; 57():e13284. PubMed ID: 38359273
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis: A part of the ALL-STAR study.
    Skipper MT; Birkebæk N; Jensen RB; Rank CU; Tuckuviene R; Wehner PS; Lambine TL; Hørlyck A; Schmiegelow K; Frandsen TL; Andrés-Jensen L; Albertsen BK
    Eur J Haematol; 2024 Jun; 112(6):944-956. PubMed ID: 38351310
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Geographic and Racial Disparities in Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials Access for Diffuse Large B-Cell lymphoma.
    Shahzad M; Khalid MF; Amin MK; Basharat A; Ammad-Ud-Din M; Park R; Anwar I; Faisal MS; Jaglal M
    Clin Lymphoma Myeloma Leuk; 2024 May; 24(5):316-322. PubMed ID: 38342727
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
    Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
    Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of flow cytometric immunophenotyping in the diagnosis of breast implant-associated anaplastic large cell lymphoma: A 6-year, single-institution experience.
    Chan A; Auclair R; Gao Q; Ghione P; Horwitz S; Dogan A; Roshal M; Lin O
    Cytometry B Clin Cytom; 2024 Mar; 106(2):117-125. PubMed ID: 38297808
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.
    Heftdal LD; Hansen CB; Hamm SR; Pérez-Alós L; Fogh K; Pries-Heje M; Hasselbalch RB; Møller DL; Gang AO; Ostrowski SR; Frikke-Schmidt R; Sørensen E; Hilsted L; Bundgaard H; Garred P; Iversen K; Sabin C; Nielsen SD; Grønbæk K
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38275946
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long-term outcomes with HLX01 (HanliKang
    Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
    BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Multicenter Study of Needle Size and Safety for Splenic Biopsy.
    Kavandi H; Itani M; Strnad B; Martin S; Ebrahimzadeh SA; Lubner MG; Noe-Kim V; Hinshaw JL; Bansal M; Karam AR; Khanna K; Hadied MO; Planz V; Glazer DI; Burgan CM; Galgano S; Brook A; Brook OR
    Radiology; 2024 Jan; 310(1):e230453. PubMed ID: 38259204
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients.
    Gandham AR; Geller S; Dusza SW; Kupper TS; Myskowski PL
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e174-e180. PubMed ID: 38245472
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma.
    Locke FL; Filosto S; Chou J; Vardhanabhuti S; Perbost R; Dreger P; Hill BT; Lee C; Zinzani PL; Kröger N; López-Guillermo A; Greinix H; Zhang W; Tiwari G; Budka J; Marincola FM; To C; Mattie M; Schupp M; Cheng P; Bot A; Shen R; Bedognetti D; Miao H; Galon J
    Nat Med; 2024 Feb; 30(2):507-518. PubMed ID: 38233586
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes.
    Rajakumaraswamy N; Gandhi M; Wei AH; Sallman DA; Daver NG; Mo S; Iqbal S; Karalliyadda R; Chen M; Wang Y; Vyas P
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):260-268.e2. PubMed ID: 38216397
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 258.